25 May 2013
Keywords: EPHA, Transparency, European drug pricing, Reimbursement
Article | 07 June 2011
In the framework of the European Commission consultation of the possible revision of the directive on the transparency of measures ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 June 2011
24 May 2013
© 2013 thepharmaletter.com